Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
CETRIMONIUM BROMIDE CHLORHEXIDINE GLUCONATE
G & A Licensing Limited
CETRIMONIUM BROMIDE CHLORHEXIDINE GLUCONATE
0.5/0.1 %w/w
Cream
Product not subject to medical prescription
Withdrawn
2011-03-24
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PPA1447/049/001 Case No: 2069001 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to G & A LICENSING LTD BALLYMURRAY, CO. ROSCOMMON, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product SAVLON ANTISEPTIC CREAM The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 08/01/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 12/01/2010_ _CRN 2069001_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Savlon Antiseptic Cream. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients: Cetrimide 0.50% w/w Chlorhexidine Gluconate 0.10% w/w Excipients: Cetostearyl alcohol Methyl hydroxybenzoate E218 Propyl hydroxybenzoate E216 For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Cream _Imported from United Kingdom_ Smooth, white, homogenous cream with an antiseptic odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For prevention and management of superficial infections in skin tissue including wounds and minor burns. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For cutaneous use. Apply to the affected area after cleansing. 4.3 CONTRAINDICAT Läs hela dokumentet